Long COVID-Fatigue Impacts 50M People – Axcella Health Seeks Funding To Support Drug Development
Axcella Health Inc (NASDAQ: AXLA) is reportedly looking for funding to support its advanced trial of a drug initially found to improve fatigue in long Covid patients.